IL125035A0 - Thieno (2,3-b) pyrazolo (3,4-d) pyridin-3-ones to enhance erythropoiesis - Google Patents
Thieno (2,3-b) pyrazolo (3,4-d) pyridin-3-ones to enhance erythropoiesisInfo
- Publication number
- IL125035A0 IL125035A0 IL12503596A IL12503596A IL125035A0 IL 125035 A0 IL125035 A0 IL 125035A0 IL 12503596 A IL12503596 A IL 12503596A IL 12503596 A IL12503596 A IL 12503596A IL 125035 A0 IL125035 A0 IL 125035A0
- Authority
- IL
- Israel
- Prior art keywords
- thieno
- pyrazolo
- pyridin
- ones
- enhance erythropoiesis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US937195P | 1995-12-29 | 1995-12-29 | |
| US1207096P | 1996-02-22 | 1996-02-22 | |
| PCT/US1996/020418 WO1997024120A1 (en) | 1995-12-29 | 1996-12-20 | THIENO(2,3-b)PYRAZOLO(3,4-d)PYRIDIN-3-ONES TO ENHANCE ERYTHROPOIESIS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL125035A0 true IL125035A0 (en) | 1999-01-26 |
Family
ID=26679395
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL12503596A IL125035A0 (en) | 1995-12-29 | 1996-12-20 | Thieno (2,3-b) pyrazolo (3,4-d) pyridin-3-ones to enhance erythropoiesis |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6107304A (xx) |
| EP (1) | EP0869790A4 (xx) |
| JP (1) | JP2000507206A (xx) |
| KR (1) | KR19990076822A (xx) |
| CN (1) | CN1211920A (xx) |
| AU (1) | AU1686797A (xx) |
| BR (1) | BR9612302A (xx) |
| CA (1) | CA2241723A1 (xx) |
| CZ (1) | CZ206498A3 (xx) |
| HU (1) | HUP9902086A3 (xx) |
| IL (1) | IL125035A0 (xx) |
| MX (1) | MX9805321A (xx) |
| NO (1) | NO983007L (xx) |
| PL (1) | PL327510A1 (xx) |
| TR (1) | TR199801251T2 (xx) |
| WO (1) | WO1997024120A1 (xx) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19904391A1 (de) * | 1999-02-04 | 2000-08-10 | Bayer Ag | Pyrazol-Alkylamide |
| DE19929787A1 (de) * | 1999-06-29 | 2001-01-04 | Bayer Ag | Neue 4-(2-Oxodihydrooxadiazinylphenyl)amide und ihre Verwendung |
| US20050084908A1 (en) * | 2000-11-06 | 2005-04-21 | Chugai Seiyaku Kabushiki Kaisha | Methods for detecting binding of low-molecular-weight compound and its binding partner molecule |
| US6833374B2 (en) | 2002-07-29 | 2004-12-21 | Wyeth | Dihydropyrazolo[3,4-d]thieno[2,3-B]pyridinone inhibitors of B7-1 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2435025C2 (de) * | 1973-07-23 | 1985-01-17 | Takeda Chemical Industries, Ltd., Osaka | 4,7-Dihydro-4-oxo-thieno-[2,3-b]pyridin-5-carbonsäure und deren Derivate und Verfahren zu deren Herstellung |
| DE2447477A1 (de) * | 1974-10-03 | 1976-04-15 | Schering Ag | Thieno-pyridoncarbonsaeurederivate, verfahren zur herstellung dieser verbindungen und ihre therapeutische verwendung |
| EP0126970A3 (en) * | 1983-04-27 | 1985-11-06 | Beecham Group Plc | Anxiolytic and anti-depressant thienopyridine derivatives |
| US4740512A (en) * | 1984-07-09 | 1988-04-26 | Ciba-Geigy Corporation | Treating anxiety with certain ring-fused pyrazolo[3,4-d]-pyridin-3-one derivatives |
| US4602014A (en) * | 1984-07-09 | 1986-07-22 | Ciba-Geigy Corporation | Ring-fused pyrazolo[3,4-d]-pyridin-3-one derivatives as benzodiazepine receptor modulators |
| US4647566A (en) * | 1984-07-09 | 1987-03-03 | Ciba-Geigy Corporation | Certain ring-fused pyrazolo[3,4-d]-pyridin-3-one derivatives in treating anxiety |
| US4814450A (en) * | 1984-07-09 | 1989-03-21 | Ciba-Geigy Corporation | Certain ring-fused pyrazolo[3,4-d]-pyridin-3-one derivatives |
| AU4440596A (en) * | 1995-02-10 | 1996-08-22 | Smithkline Beecham Corporation | Use of hcp SH2 specific compounds to enhance erythropoiesis |
| EP0727211A1 (en) * | 1995-02-10 | 1996-08-21 | Smithkline Beecham Corporation | Use of src SH2 specific compounds to treat a bone resorption disease |
-
1996
- 1996-12-20 EP EP96945632A patent/EP0869790A4/en not_active Withdrawn
- 1996-12-20 CZ CZ982064A patent/CZ206498A3/cs unknown
- 1996-12-20 TR TR1998/01251T patent/TR199801251T2/xx unknown
- 1996-12-20 PL PL96327510A patent/PL327510A1/xx unknown
- 1996-12-20 JP JP09524480A patent/JP2000507206A/ja active Pending
- 1996-12-20 AU AU16867/97A patent/AU1686797A/en not_active Abandoned
- 1996-12-20 KR KR1019980704948A patent/KR19990076822A/ko not_active Application Discontinuation
- 1996-12-20 IL IL12503596A patent/IL125035A0/xx unknown
- 1996-12-20 WO PCT/US1996/020418 patent/WO1997024120A1/en not_active Application Discontinuation
- 1996-12-20 BR BR9612302A patent/BR9612302A/pt not_active Application Discontinuation
- 1996-12-20 CN CN96180144A patent/CN1211920A/zh active Pending
- 1996-12-20 HU HU9902086A patent/HUP9902086A3/hu unknown
- 1996-12-20 CA CA002241723A patent/CA2241723A1/en not_active Abandoned
-
1998
- 1998-06-26 NO NO983007A patent/NO983007L/no not_active Application Discontinuation
- 1998-06-29 MX MX9805321A patent/MX9805321A/es unknown
-
1999
- 1999-06-07 US US09/327,249 patent/US6107304A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO1997024120A1 (en) | 1997-07-10 |
| KR19990076822A (ko) | 1999-10-15 |
| CN1211920A (zh) | 1999-03-24 |
| EP0869790A4 (en) | 2001-04-11 |
| HUP9902086A3 (en) | 2001-09-28 |
| JP2000507206A (ja) | 2000-06-13 |
| TR199801251T2 (xx) | 1998-10-21 |
| NO983007L (no) | 1998-08-26 |
| US6107304A (en) | 2000-08-22 |
| BR9612302A (pt) | 1999-07-13 |
| CA2241723A1 (en) | 1997-07-10 |
| PL327510A1 (en) | 1998-12-21 |
| MX9805321A (es) | 1998-10-31 |
| EP0869790A1 (en) | 1998-10-14 |
| AU1686797A (en) | 1997-07-28 |
| CZ206498A3 (cs) | 1998-11-11 |
| HUP9902086A2 (hu) | 1999-11-29 |
| NO983007D0 (no) | 1998-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP9801336A3 (en) | 6-substituted pyrazolo[3,4-d]pyrimidin-4-ones and pharmaceutical compositions containing them | |
| SI1001955T1 (en) | 1,2,4-triazolo 4,3-b)pyrido 3,2-d)pyridazine derivatives and pharmaceutical compositions containing them | |
| ZA892968B (en) | 6-aryl-substituted-4h-thieno(2,3-e)(1,2,4)triazolo(3,4-c)(1,4)-diazepines | |
| IL125035A0 (en) | Thieno (2,3-b) pyrazolo (3,4-d) pyridin-3-ones to enhance erythropoiesis | |
| AU552765B2 (en) | Pyrazolo(4,3-e)-pyrido(3,2-b)(1,4) diazepin-10-ones | |
| CS314991A3 (en) | Substituted thieno/3,3-b/pyran-5,7-diones | |
| ZA9610860B (en) | Thieno[2,3-b]pyrazolo[3,4-d]pyridin-3-ones as HCP SH2 antagonist to enhance erythropoiesis. | |
| GB9223108D0 (en) | Hexahydropyrrolo (2,3-b)indole derivatives | |
| GB2083460B (en) | Pyrrolo (3,4-d) (2) benzazepines | |
| IE842874L (en) | THIENO (2,3-b) PYRROLE DERIVATIVES | |
| IE882359L (en) | THIENO (2, 3-b) THIOPHENES | |
| EP0480692A3 (en) | Substituted 4,5-dihydrothieno(2,3-b)thiophene-2-sulfonamides | |
| IE832955L (en) | THIENO £2,3-b| PYRROLE DERIVATIVES | |
| IE883735L (en) | Thieno (3,4-b) benzodiazepinones | |
| IE840033L (en) | HETEROCYCLE-FUSED PYRAZOLO £3,4-d| PYRIDIN-3-ONE | |
| JPS5758684A (en) | Pyrrolo(3,4-d)(2)benzazepines | |
| IE870673L (en) | PYRAZOLO (3,4-d) PYRIMIDINES | |
| ZA918480B (en) | Substituted thieno(3,2-b)pyran-5,7-diones | |
| IE841396L (en) | TRIAZOLO £2,3-c| £1,3| BENZODIAZEPINES | |
| HU9204124D0 (en) | 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-pyrrholo/2,3-b/-indole-tetrahydro-isoquinoline-urea derivatives | |
| IE892391L (en) | PYRIDO (3,4-f) PYRROLO (1,2-b) (1,2,5) TRIAZEPINES | |
| AU558354B2 (en) | Pyrrolo(3,4-d)(2)benzazepines | |
| IE851649L (en) | PYRROLO (1,2-b) TRIAZEPINE | |
| IE852456L (en) | Thieno (or furano) pyrroles | |
| KR100199834B1 (en) | Tetrahydroisoquinolinylcarbamates of 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b]indole |